左金丸调控DSS结肠炎小鼠肠道菌群与Treg细胞相关性
本研究以DSS诱导结肠炎小鼠为对象,给予左金丸治疗7天,通过宏观微观观察、流式细胞术、16S rRNA分析和Western blotting评价疗效与机制。结果显示左金丸减轻病理损伤、降低促炎因子,调节肠道菌群多样性及放线菌纲、鞘脂杆菌纲相对丰度,提升CD4+CD25+Foxp3+和PD-L1+ Treg细胞水平,且这些变化呈正相关,并抑制PI3K/Akt信号通路活化。结论认为左金丸通过PI3K/Akt通路调控肠道菌群与Treg细胞互作以减轻实验性结肠炎。
要点
- 左金丸可减轻DSS诱导小鼠结肠炎病理损伤并降低促炎因子表达。
- 左金丸调节肠道菌群多样性及放线菌纲、鞘脂杆菌纲相对丰度。
- 左金丸提升CD4+CD25+Foxp3+和PD-L1+ Treg细胞水平并抑制PI3K/Akt通路。
核心结论
- 左金丸通过PI3K/Akt信号通路调控肠道菌群与Treg细胞互作,从而减轻实验性结肠炎。
研究设计与样本
- DSS诱导结肠炎小鼠模型,左金丸治疗7天。
- 采用宏观和微观观察评价疗效,流式细胞术分析Treg细胞及其亚群,16S rRNA分析肠道菌群组成,Western blotting观察PI3K/Akt通路活化。
主要发现
- 病理损伤减轻,促炎细胞因子表达下降。
- 肠道菌群多样性受调节,放线菌纲和鞘脂杆菌纲相对丰度改变。
- CD4+CD25+Foxp3+和PD-L1+ Treg细胞水平提高,且这些变化经统计学分析呈正相关。
- 左金丸抑制PI3K/Akt信号通路活化。
临床怎么用
- 左金丸可能通过调节肠道菌群与Treg细胞互作及抑制PI3K/Akt通路,用于溃疡性结肠炎的治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: As a classic prescription and commercial Chinese patent medicine, Zuojin Pill (ZJP) has been used to treat ulcerative colitis (UC) effectively for many years. However, its mechanism of action remains unclear. AIM OF THE STUDY: METHODS: Mice with dextran-sulfate-sodium-induced colitis were treated with ZJP for 7 d. In the present study, the therapeutic effect of ZJP was evaluated by macroscopic and microscopic observation; regulatory T (Treg) cells and their subsets were analyzed by flow cytometry; and the composition of gut microbiota was tested by 16S rRNA analysis. Activation of the phosphoinostide 3-kinase (PI3K)/Akt signaling pathway was observed by western blotting. RESULTS: The pathological damage was attenuated and expression of proinflammatory cytokines was decreased. While the diversity of intestinal microflora was regulated, the relative abundance of Actinobacteria, and Sphingobacteriia was modified. Meanwhile, the level of CD4+CD25+Foxp3+ and PD-L1+ Treg cells improved. These changes maintained a positive correlation which was analyzed statistically. Our results also showed that ZJP inhibited activation of the PI3K/Akt signaling pathway. CONCLUSIONS: ZJP regulates crosstalk between intestinal microflora and Treg cells to attenuate experimental colitis via the PI3K/Akt signaling pathway.
引用
- Zhou BG, Liu FC, Zhao HM, et al. Regulatory effect of Zuojin Pill on correlation with gut microbiota and Treg cells in DSS-induced colitis. J Ethnopharmacol. 2020. PMID: 32739566. doi:10.1016/j.jep.2020.113211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。